Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events.

Abstract

Transcatheter aortic valve implantation (TAVI) has emerged as a therapeutic alternative for patients with symptomatic aortic stenosis at high or prohibitive surgical risk. However, patients undergoing TAVI are also at high risk for both bleeding and stroke complications, and specific mechanical aspects of the procedure itself can increase the risk of these… (More)
DOI: 10.1016/j.jacc.2013.03.029

Topics

5 Figures and Tables

Cite this paper

@article{RodsCabau2013AntithromboticTI, title={Antithrombotic treatment in transcatheter aortic valve implantation: insights for cerebrovascular and bleeding events.}, author={Josep Rod{\'e}s-Cabau and Harold L. Dauerman and Mauricio G Cohen and Roxana Mehran and Eric M. Small and Susan S. Smyth and Marco A. Costa and Jessica L. Mega and Michelle L. O'Donoghue and E. Magnus Ohman and Richard C. Becker}, journal={Journal of the American College of Cardiology}, year={2013}, volume={62 25}, pages={2349-2359} }